Trial intelligence / Profile preview

ABACOPD: Sultamicillin vs Placebo in Moderate AE-COPD

NCT01892488Phase 4Completed

Sponsor
Hannover Medical School
Start
Jun 2013
Primary completion
Apr 2019
Countries
1
01

Overview

A Phase 4 trial of sultamicillin in chronic obstructive pulmonary disease (COPD), sponsored by Hannover Medical School. Started Jun 2013; status: completed.

02

Drugs

sultamicillin
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT01892488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01892488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call